AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums
April 09, 2019 09:35 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today...
AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) for Psoriasis and Eczema in Patients
May 17, 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce to shareholders and the public that the Company is launching human dermatological clinical...
Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board
August 26, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...
AXIM Biotech Presents Patented Cannabinoid Delivery Methods at My Compassion's Chicago Cannabis Conference
July 29, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 29, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) CEO George E. Anastassov, MD, DDS, MBA, proudly shared the Company's cannabinoid delivery methods – including...
Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend
July 02, 2015 12:08 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 2, 2015 (GLOBE NEWSWIRE) -- When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our...
Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products
April 20, 2015 15:12 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in...
Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board
March 18, 2015 12:31 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 18, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease...
Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products
March 05, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 5, 2015 (GLOBE NEWSWIRE) -- New York-based AXIM Biotechnologies, Inc. (OTC:AXIM) proudly presented its line of the world's first oral care and cosmetic products that include...